Skip to content

Clinical trials

Phase 2 Bronchitis, Chronic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchitis, Chronic Phase: Phase 2 Country / region: United States Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20071
20084
20094
20112
20121
20151
20171
20201
20221
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Recruiting2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline4
AstraZeneca3
Boehringer Ingelheim2
Abgenix1
Adams Respiratory Therapeutics1
Beth Israel Deaconess Medical Center1
BioMarck Pharmaceuticals, Ltd.1
Eli Lilly and Company1
Mesoblast, Inc.1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchitis, Chronic22
Pulmonary Disease, Chronic Obstructive21
Emphysema10
Inflammation2
Lung Diseases2
Pulmonary Emphysema2
Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome1
Bronchitis1
Dyspnea1
Pneumonia1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.